- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on oGVHD
Total 147 results
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
-
Fujian Medical UniversityUnknown
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Sichuan UniversityRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversitätsklinikum Hamburg-Eppendorf; The Chaim Sheba Medical Center; Hospital...CompletedAcute Leukemia | Stem Cell Transplant Complications | GVHD, ChronicItaly
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingGVHD | Relapse | Engraft Failure
-
University of Maryland, BaltimoreRecruitingDry Eye Disease | oGVHDUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Heart, Lung, and Blood Institute (NHLBI); CTI BioPharmaCompletedGVHD | Graft Vs Host DiseaseUnited States
-
Peking University People's HospitalCompletedLeukemia, GVHD, ATG, TransplantationChina
-
Massachusetts General HospitalSeagen Inc.TerminatedGVHD | Graft-vs-Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedGraft Versus Host Disease | GVHDUnited States
-
Shanghai Jiao Tong University School of MedicineShanghai Clinical Research CenterNot yet recruiting
-
Massachusetts General HospitalNovartisTerminatedGraft Versus Host DiseaseUnited States
-
Massachusetts Eye and Ear InfirmaryCompletedSafety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseOcular GVHDUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
NYU Langone HealthCompleted
-
VectivBio AGActive, not recruiting
-
University of SalamancaHaematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo...UnknownGraft-vs-Host Disease (GVHD)Spain
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
Hadassah Medical OrganizationCompleted
-
Dana-Farber Cancer InstituteCompletedGraft vs Host Disease | Chronic Graft vs Host Disease | cGVHDUnited States
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft Versus Host Disease | GVHDUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Karolinska University HospitalCompletedAML | ALL | Acute GVHD | Tumor ImmunitySweden
-
M.D. Anderson Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
Dimitrios Tzachanis, MD PhDBristol-Myers SquibbActive, not recruitingHematologic Neoplasms | GVHDUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease (GVHD)United States
-
Shanghai Children's Medical CenterBioMérieuxUnknownGVHD - Graft-Versus-Host Disease
-
Shanghai Children's Medical CenterUnknownFecal Microbiota Transplantation for Treatment of Refractory Graft Versus Host Disease-a Pilot StudyFecal Microbiota Transplantation in GVHD
-
Henry Ford Health SystemRecruiting
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematologic MalignancyUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Lophius Biosciences GmbHGerman Federal Ministry of Education and ResearchCompletedClinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients (AlloProtectCMV)Cytomegalovirus Infection | GVHDGermany
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRecruitingRefractory Chronic Graft Versus Host Disease (cGVHD)Belgium
-
The Korean Society of Hematopoietic Stem Cell TransplantationHoffmann-La RocheUnknownSteroid-Refractory Chronic GVHDKorea, Republic of
-
Anhui Provincial HospitalRecruitingSteroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)China
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingImmune Mediated Anemia | Immune Mediated Thrombocytopenia | Chronic GVHDUnited States
-
Leland MethenyWithdrawnGastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)United States
-
University of PisaUnknownNeutropenic Enterocolitis | Intestinal GVHDItaly
-
Children's Hospital Medical Center, CincinnatiTerminatedGraft Versus Host Disease (GVHD) | Diagnoses That Require Stem Cell TransplantUnited States
-
Nationwide Children's HospitalTerminatedGraft Versus Host Disease | Acute GVH Disease | Steroid Refractory GVHDUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States